Health
Saudi's Space Mission will be for the Benefit of Science
RIYADH, Saudi Arabia, March 21, 2023 /PRNewswire/ -- The Saudi Space Commission (SSC) have revealed the tasks and scientific research that will be conducted during the journey of the Saudi astronauts, Rayyanah Barnawi andAli Alqarni as part of the mission to the International Space Station (ISS),...
2023-03-21 00:31
1889
Sirnaomics to Present Latest Developments in Polypeptide Nanoparticle Platform at the 4th Annual RNAi-Based Therapeutics Summit
HONG KONG and GERMANTOWN, Md. and SUZHOU BIOBAY, China, March 20, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, and together with its subsidiaries, the"Group" or "Sirnaomics"), a leading biopharmaceutical company in the discovery and development of advanced RNAi thera...
2023-03-20 23:27
2480
Transcenta Holding Limited (6628.HK) to Hold 2022 Annual Results Release Conference Call
SUZHOU, China, March 20, 2023 /PRNewswire/ -- The management team of Transcenta Holding Limited (06628.HK) will attend the 2022 annual results release conference call onMarch 31, 2023. Transcenta is a clinical stage biopharmaceutical company with fully integrated capabilities in the discovery, r...
2023-03-20 21:12
1962
Building Back: Helping Young People Go from Recovery to Discovery
Outward Bound International releases timely and relevant report about the role of outdoor learning in addressing youth mental health and helping young people build back post pandemic. NEW YORK, March 20, 2023 /PRNewswire/ -- Outward Bound International, the coordinating organization for Outward ...
2023-03-20 21:00
1722
Hovione and Ripple Enter Strategic Partnership to Expand Epidel® Platform into Non-Ophthalmic Space
LISBON, Portugal, March 20, 2023 /PRNewswire/ -- Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and Ripple Therapeutics, a leading ophthalmic sustained drug delivery company, have entered a strategic partnership to expand the use of Ripple's Epidel® plat...
2023-03-20 21:00
1606
Lunit Meets MDR CE Requirements for 3D Breast Tomosynthesis AI Solution
* Lunit set to launch Lunit INSIGHT DBT in the European market * Lunit seeks FDA clearance, paving the way into the US market SEOUL, South Korea, March 20, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer solutions, today announced that its AI solution...
2023-03-20 21:00
1509
CNEY Wins a Large Activated Carbon Order
LISHUI, China, March 20, 2023 /PRNewswire/ -- CN Energy Group. Inc. (NASDAQ: CNEY) ("CNEY", or the "Company") today announced that its wholly-owned subsidiary, Zhejiang CN Energy New Materials Co., Ltd., has recently signed a contract to supply its high-quality wood-based activated carbon to a bu...
2023-03-20 20:30
1868
I-Mab to Report Full Year 2022 Financial Results and Provide Corporate Update on March 31, 2023
GAITHERSBURG, Md. and SHANGHAI, China, March 20, 2023 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the Company will report financial results ...
2023-03-20 20:00
1954
Guo Guangchang Stresses Healthy Corporate Development and Expresses Full Confidence in the Future
HONG KONG, March 20, 2023 /PRNewswire/ -- On 17 and 18 March, Guo Guangchang, Chairman of Fosun International, attended the 23rd Annual Conference of Yabuli China Entrepreneurs Forum 2023, and the 6th Shanghai Forum Themed Zhejiang Entrepreneurs in the World & the 11th Member Representative Confe...
2023-03-20 17:12
2391
ETANA HAS SECURED FINANCING FROM DEG, EAST VENTURES AND OTHER GLOBAL INVESTORS
JAKARTA, Indonesia, March 20, 2023 /PRNewswire/ -- PT Etana Biotechnologies Indonesia (Etana), an Indonesian biopharmaceutical company, has secured a new round of investment led by DEG followed by Yunfeng Capital, HighLight Capital and East Ventures. This round of financing will be used for fu...
2023-03-20 15:22
2956
Antengene Announces Five Upcoming Presentations at the 2023 American Association for Cancer Research Annual Meeting
– Five posters will showcase progress with multiple preclinical and clinical programs, including the clinical results ofATG-008 (mTORC1/2 inhibitor) and preclinical data ofATG-031 (anti-CD24 monoclonal antibody), ATG-037 (small molecule CD73 inhibitor), ATG-017 (ERK1/2 inhibitor), and ATG-034 (L...
2023-03-20 15:20
1942
Agilis Robotics has kickstarted its first trial in mainland China, taking a great leap forward in robotized endoscopic surgery in the country
HONG KONG, March 20, 2023 /PRNewswire/ -- Agilis Robotics is a company that is revolutionizing the world of endoscopic surgery. The company has developed the world's smallest flexible and dexterous endoscopic robot system, which is a breakthrough in the field of robotics surgery. The Agilis Robo...
2023-03-20 14:30
2332
Innovating for better sleep
BEIJING, March 20, 2023 /PRNewswire/ -- Sleep is essential for health. Like eating well and exercising, sleep is a behavior that is essential to a person's physical, mental, and social well-being. However, sleep is not yet universally recognized as an essential behavior for physical health.1 BMC...
2023-03-20 10:00
2412
AffaMed Technologies Announces TFDA Approval of MINI WELL, MINI WELL PROXA, MINI WELL TORIC and MINI 4 Ready IOLs for Cataract Treatment in Taiwan
SHANGHAI, March 20, 2023 /PRNewswire/ -- AffaMed Technologies, a joint venture established between AffaMed Therapeutics and SIFI S.p.A., today announced that the Taiwan Food and Drug Administration ("TFDA") has approved its MINI WELL, MINI WELL PROXA, MINI WELL TORIC and MINI 4 Ready intraocular ...
2023-03-20 09:00
2991
320 World Oral Health Day - Lifting the "mask mandate", maintaining good oral hygiene and flashing a healthy and confident smile.
HONG KONG, March 20, 2023 /PRNewswire/ -- According to a report released by the World Health Organization (WHO) in 2022, oral diseases are the most common non-communicable diseases in humans and affect 3.5 billion people worldwide. Approximately 2 billion people have untreated caries in permanent...
2023-03-20 09:00
796
Izokibep Phase 2b/3 Hidradenitis Suppurative Data Presented at the 2023 American Academy of Dermatology Annual Meeting
* At 12 weeks, participants achieved high orders of HiSCR responses (HiSCR75 and above), including 33% achieving HiSCR100. * Safety results were consistent with previous trials of izokibep and the IL-17Ai class, with no increased risk of infection, including candida. SAN DIEGO ,SHANGHAI and SY...
2023-03-20 08:41
2468
AMGEN AND NSG BIOLABS ANNOUNCE ALBATROZ THERAPEUTICS AS WINNER OF FIRST AMGEN GOLDEN TICKET IN SINGAPORE
The Golden Ticket will help to boost the biotech startup's capabilities and to develop further the emerging biotech ecosystem inSoutheast Asia SINGAPORE, March 20, 2023 /PRNewswire/ -- Leading global biotechnology company Amgen and NSG BioLabs,Singapore's largest and leading provider of biotechn...
2023-03-20 08:00
2283
FDI World Dental Federation calls for global leaders to prioritise action against oral diseases at major UN meeting on health
Call issued on World Oral Health Day, as data shows oral diseases impact nearly
half the world's population
GENEVA, March 20, 2023 /PRNewswire/ --
- Picture is available at AP Images (http://www.apimages.com
2023-03-20 06:00
2359
Keymed Biosciences Announces 2022 Annual Results: Efficiently Promotes Clinical Progress & Proactively Develops Global Strategic Collaboration
CHENGDU, China, March 17, 2023 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) announced its 2022 annual results. Focused on unmet clinical needs, the Company continued to efficiently develop innovative and differentiated pipelines, proactively carry out global strategic collaboration and a...
2023-03-18 08:00
5457
Hanmi Pharmaceutical's Combination Drug for Dyslipidemia Treatment, 'Rosuzet': Confirmed Non-inferiority Efficacy and Safety Compared to Monotherapy in 'The Lancet' & 'European Heart Journal'
SEOUL, South Korea, March 17, 2023 /PRNewswire/ -- Hanmi Pharmaceuticals (128940.KS), a subsidiary of Hanmi Science (008930.KS) in Korea, announced that the results of large-scale clinical trial with Rosuzet have been published in 'The Lancet' and the 'European Heart Journal'. R&D-oriented pha...
2023-03-17 21:00
3561
Week's Top Stories
Most Reposted
Thailand Tops 2024 Consumer Review Awards by Agoda
[Picked up by 329 media titles]
2024-09-26 11:00
WARHAMMER 40,000: SPACE MARINE VR - DEFENDERS OF AVARAX NOW AVAILABLE AT ZERO LATENCY VR VENUES WORLDWIDE
[Picked up by 314 media titles]
2024-09-26 00:00
Advantech Unveils Expanded Singapore Office to Boost ASEAN Presence and Support AIoT Innovations with Strategic Partnerships
[Picked up by 312 media titles]
2024-09-23 13:37
Circles Partners with Telkomsel, Providing an Advanced Software-as-a-Service (SaaS) Platform to Enhance Customer Digital Experience
[Picked up by 297 media titles]
2024-09-27 10:00RuggON Debuts at the Largest Mining Expo, MINExpo 2024 Showcasing Rugged Solutions for the Trillion-Dollar Mining Market
[Picked up by 294 media titles]
2024-09-23 22:00
Most Read
WARHAMMER 40,000: SPACE MARINE VR - DEFENDERS OF AVARAX NOW AVAILABLE AT ZERO LATENCY VR VENUES WORLDWIDE
2024-09-26 00:00
8969
Thailand Tops 2024 Consumer Review Awards by Agoda
2024-09-26 11:00
7816
RuggON Debuts at the Largest Mining Expo, MINExpo 2024 Showcasing Rugged Solutions for the Trillion-Dollar Mining Market
2024-09-23 22:00
6954
Advantech Unveils Expanded Singapore Office to Boost ASEAN Presence and Support AIoT Innovations with Strategic Partnerships
2024-09-23 13:37
6343
Sobot Reflects on its Partnership with Lilith Games on Lilith's 11th Anniversary
2024-09-24 10:00
5555
